CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Roth Capital Initiates Exagen at Buy With $8 Price Target

Positive
AI Analysis

Summary

Roth Capital initiated coverage of Exagen with a Buy rating and $8 price target.

Importance:2/10
Sentiment:
0.60
analyst_coverageprice_targetbuy_rating
Related Companies

Read the original article

Published by yahoo_finance on June 25, 2026 11:24 AM

Read Original